Coronary Artery Bypass Clinical Trial
Official title:
Roxadustat Reduces the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting: a Multicenter, Randomized, Double-blind, Placebo-controlled Study
Acute kidney injury is a frequent complication after coronary artery bypass grafting (CABG). Roxadustat is a prolyl hydroxylase inhibitor (PHI) which can stabilize hypoxia-inducible factor (HIF) and improve the hypoxic tolerance of tissues. Roxadustat has shown effect in reducing acute kidney injury in animal studies. This study aims to evaluate the efficacy of administration of Roxadustat before surgery in the prevention of acute kidney injury after CABG.
Acute kidney injury is a frequent complication after coronary artery bypass grafting (CABG), with a incidence of 28-38%. Renal ischemia-reperfusion injury is the main mechanism for acute kidney injury after CABG. Roxadustat is a kind of prolyl hydroxylase inhibitor (PHI) which can stabilize hypoxia-inducible factor (HIF) and improve the hypoxic tolerance of tissues. Roxadustat has shown effect in reducing acute kidney injury in animal studies. This study aims to evaluate the efficacy of administration of Roxadustat (before surgery) in the prevention of acute kidney injury after CABG. This is a multicenter, randomized, double-blind, placebo-controlled study. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03235323 -
Efficacy of External CounterPulsation for Postoperative Coronary Artery Bypass Grafting Patients
|
N/A | |
Completed |
NCT05036044 -
Stroke and Carotid-Cerebral Vascular Disease After CABG
|
||
Completed |
NCT03622671 -
Fibrin Clot Properties and Blood Loss Following Coronary Artery By-pass Grafting
|
N/A | |
Completed |
NCT00400790 -
Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane
|
N/A | |
Not yet recruiting |
NCT03275220 -
Assessment Of Right Ventricular Function In Patients Undergoing Coronary Artery Bypass Graft In Assiut University
|
N/A | |
Completed |
NCT01256372 -
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
|
Phase 2 | |
Completed |
NCT00489827 -
Glutamate for Metabolic Intervention in Coronary Surgery
|
Phase 3 | |
Completed |
NCT04591119 -
Transversus Thoracis Muscle Plane Block for Postoperative Pain in Adult Cardiac Surgery
|
N/A | |
Active, not recruiting |
NCT03908593 -
Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG
|
Phase 4 | |
Recruiting |
NCT03774342 -
The Influence of Cognitive Decline on Quality of Life After Coronary Bypass
|
||
Enrolling by invitation |
NCT03999398 -
Short and Long-term Results of PCI in no Touch Vein-graft.
|
||
Recruiting |
NCT05414331 -
WithDRawal Impact Of Postoperative Beta-Blocker
|
N/A | |
Completed |
NCT02981680 -
Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery
|
N/A | |
Completed |
NCT00600704 -
Impact of Fluid Restriction Policy in Reducing the Use of Red Cells in Cardiac Surgery
|
N/A | |
Completed |
NCT06013605 -
Effect of Walking Exercise on Functional Capacity and Productivity in Patients After Coronary Artery Bypass Graft
|
N/A | |
Active, not recruiting |
NCT02731794 -
On-pump Beating Coronary Artery Bypass Grafting by Ventricular Assist
|
Phase 4 | |
Completed |
NCT02722213 -
Mindfulness & Stress Management Study for Cardiac Patients
|
N/A | |
Completed |
NCT01285271 -
A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon
|
Phase 3 | |
Completed |
NCT00911976 -
Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft Lesions
|
Phase 4 | |
Completed |
NCT00823082 -
Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
|
Phase 2 |